(Q44772502)

6 December 2017

title

Effects of inhaled furosemide on exertional dyspnea in chronic obstructive pulmonary disease (English)

1 reference

chronic obstructive pulmonary disease

6 December 2017

main subject

1 reference

1 reference

Kian-Chung Ong

1

1 reference

6 December 2017

Ai-Ching Kor

2

1 reference

6 December 2017

Wai-Fung Chong

3

1 reference

6 December 2017

Arul Earnest

4

1 reference

6 December 2017

Yee-Tang Wang

5

1 reference

6 December 2017

language of work or name

English

0 references

publication date

20 February 2004

1 reference

American Journal of Respiratory and Critical Care Medicine

6 December 2017

published in

1 reference

6 December 2017

volume

169

1 reference

6 December 2017

issue

9

1 reference

6 December 2017

page(s)

1028-1033

1 reference

Prevention of exercise-induced bronchoconstriction by inhaled frusemide

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200308-1171OC

Inhaled frusemide is highly effective in preventing ultrasonically nebulised water bronchoconstriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200308-1171OC

Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200308-1171OC

Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200308-1171OC

Inhaled furosemide inhibits behavioral response to airway occlusion in anesthetized cats

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200308-1171OC

Nebulized furosemide as a novel treatment for dyspnea in terminal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200308-1171OC

Effect of nebulized furosemide in terminally ill cancer patients with dyspnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200308-1171OC

Re: nebulized furosemide for dyspnea in terminal cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200308-1171OC

Furosemide protective effect against airway obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200308-1171OC

Effect of frusemide on airway smooth muscle contractility in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200308-1171OC

Loop diuretics and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200308-1171OC

Responses of tracheobronchial receptors to inhaled furosemide in anesthetized rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200308-1171OC

Neural regulation of airway smooth muscle tone

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200308-1171OC

Effects of inhaled furosemide on CO(2) ventilatory responsiveness in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200308-1171OC

A Systematic Review of the Effects of Bronchodilators on Exercise Capacity in Patients With COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200308-1171OC

Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow limitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200308-1171OC

10.1164/RCCM.200308-1171OC

21 January 2018

Identifiers

DOI

1 reference

release_n5v6gma2rnbirkjfnbaiu4k5ua

6 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/n5v6gma2rnbirkjfnbaiu4k5ua

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference